1. 8. Electrophysiological and phenotypic profiles of taxane-induced neuropathy. Issue 3 (March 2020) Authors: Timmins, Hannah C.; Li, Tiffany; Huynh, William; Kiernan, Matthew C.; Baron-Hay, Sally; Marx, Gavin; Boyle, Frances; Goldstein, David; Park, Susanna B. Journal: Clinical neurophysiology Issue: Volume 131:Issue 3(2020:Mar.) Page Start: e4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pathological outcomes of HER2‐positive non‐metastatic breast cancer patients treated with neoadjuvant dual anti‐HER2 therapy and taxane: An Australian experience. Issue 3 (19th June 2019) Authors: Choi, Joseph Do Woong; Hughes, Thomas Michael D.; Marx, Gavin; Rutovitz, Josie; Hasovits, Csilla; Ngui, Nicholas K. Journal: Asia-Pacific journal of clinical oncology Issue: Volume 16:Issue 3(2020) Page Start: 103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial. Issue 3 (March 2022) Authors: Smith, Matthew R; Scher, Howard I; Sandhu, Shahneen; Efstathiou, Eleni; Lara, Primo N; Yu, Evan Y; George, Daniel J; Chi, Kim N; Saad, Fred; Ståhl, Olof; Olmos, David; Danila, Daniel C; Mason, Gary E; Espina, Byron M; Zhao, Xin; Urtishak, Karen A; Francis, Peter; Lopez-Gitlitz, Angela; Fizazi, Ka... Journal: Lancet oncology Issue: Volume 23:Issue 3(2022) Page Start: 362 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials. Issue 9 (September 2017) Authors: Adams, Richard; Bateman, Andrew; Blesing, Claire; Brown, Ewan; Chau, Ian; Cummins, Sebastian; Cunningham, David; Falk, Stephen; Hadaki, Maher; Hall, Marcia; Hickish, Tamas; Hornbuckle, Joanne; Lofts, Fiona; Lowndes, Sarah; Mayer, Astrid; Metcalfe, Matthew; Middleton, Gary; Mills, Jamie; Montazeri... Journal: Lancet oncology Issue: Volume 18:Issue 9(2017:Sep.) Page Start: 1159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Pertuzumab study in the neoadjuvant setting for HER2‐positive nonmetastatic breast cancer in Australia (PeRSIA). Issue 2 (25th August 2022) Authors: Lok, Sheau Wen; De Boer, Richard; Baron‐Hay, Sally; Button, Peter; Devitt, Bianca; Forster, Benjamin C.; Fox, Peter; Harold, Michael; Ketheeswaran, Sahisha; Kichenadasse, Ganessan; Kiely, Belinda E.; Marx, Gavin; Nott, Louise; Pellegrini, Laura; Tafreshi, Ali; Gibbs, Peter Journal: International journal of cancer Issue: Volume 152:Issue 2(2023) Page Start: 267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Drug reaction with eosinophilia and systemic symptoms in metastatic basal cell carcinoma treated with vismodegib. (February 2017) Authors: Thomas, Charlotte L; Arasaratnam, Malmaruha; Carlos, Giuliana; Parasyn, Andrew; Baumgart, Karl W; Fernandez‐Penas, Pablo; Marx, Gavin Journal: Australasian journal of dermatology Issue: Volume 58:Number 1(2017) Page Start: 69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Demonstrating the feasibility of collecting secondary, de‐identified data on Australian patients receiving treatment as part of a Medicine Access Programme. Issue 1 (14th January 2020) Authors: Lok, Sheau W.; De Boer, Richard; Cordwell, Cassandra; Marx, Gavin; Fox, Peter; Hasovits, Csilla; Rutovitz, Joseph; Harold, Michael; Tran, Ben; Wong, Hui‐Li; Gibbs, Peter Journal: Internal medicine journal Issue: Volume 50:Issue 1(2020) Page Start: 99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Efficacy of management strategies for aromatase inhibitor‐induced arthralgia in breast cancer patients: a systematic review. (30th January 2018) Authors: Nahm, Nicole; Mee, Susie; Marx, Gavin Journal: Asia-Pacific journal of clinical oncology Issue: Volume 14(2018)Supplement 6 Page Start: 374 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Factors associated with the development and severity of oxaliplatin‐induced peripheral neuropathy: a systematic review. Issue 6 (27th June 2017) Authors: Pulvers, Jeremy N.; Marx, Gavin Journal: Asia-Pacific journal of clinical oncology Issue: Volume 13:Issue 6(2017) Page Start: 345 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Primary treatment of the prostate improves local palliation in men who ultimately develop castrate‐resistant prostate cancer. (23rd July 2013) Authors: Won, Andy C.M.; Gurney, Howard; Marx, Gavin; De Souza, Paul; Patel, Manish I. Journal: BJU international Issue: Volume 112:Number 4(2013:Aug.) Page Start: E250 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗